Mononucleosis Diagnostic Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Test Type (Epstein Barr Virus (EBV) Antibody Test, Complete Blood Count Test, Monospot Test); End User (Hospitals, Laboratories, Other End Users), and Geography

Report Code: TIPRE00019689 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Mononucleosis diagnostics is done to determine the presence of the Epstein-Barr virus (EBV). The test is suggested after a patient is showing signs and symptoms such as swollen lymph nodes, tonsils, liver, or spleen. Several tests are available, such as the monospot test, complete blood count test, and Epstein Barr virus (EBV) antibody test.

MARKET DYNAMICS

The mononucleosis diagnostic market growth is estimated to grow due to growing developments for diagnostics technologies, growing diagnostics facilities and product availability, and increasing the biotechnology sector. The market is expected to have growth opportunities due to increasing AIDS, strep throat, and Lyme disease in developing regions.

MARKET SCOPE

The "Mononucleosis Diagnostic Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of mononucleosis diagnostic market with detailed market segmentation by test type, and end user. The mononucleosis diagnostic market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in mononucleosis diagnostic market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The mononucleosis diagnostic market is segmented on the basis of test type, and end user. Based on test type, the market is classified as epstein barr virus (EBV) antibody test, complete blood count test, and monospot test. On the basis of end user, the market is segmented as for hospitals, laboratories, and other end users.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the mononucleosis diagnostic market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mononucleosis diagnostic market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting mononucleosis diagnostic market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the mononucleosis diagnostic market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the mononucleosis diagnostic market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from mononucleosis diagnostic market are anticipated to have lucrative growth opportunities in the future with the rising demand for mononucleosis diagnostic market in the global market. Below mentioned is the list of few companies engaged in the mononucleosis diagnostic market.

The report also includes the profiles of key players in mononucleosis diagnostic market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott
  •  Bio-Rad Laboratories, Inc.
  •  Thermo Fisher Scientific Inc.
  •  Danaher Corporation
  •  Cardinal Health, Inc.
  •  F. Hoffmann-La Roche Ltd
  •  Immunostics Inc.
  •  Quidel Corporation
  •  Sekisui Diagnostics
  •  Meridian Bioscience

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mononucleosis Diagnostic Market - By Test Type
1.3.2 Mononucleosis Diagnostic Market - By End User
1.3.3 Mononucleosis Diagnostic Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MONONUCLEOSIS DIAGNOSTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MONONUCLEOSIS DIAGNOSTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MONONUCLEOSIS DIAGNOSTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. MONONUCLEOSIS DIAGNOSTIC - GLOBAL MARKET OVERVIEW
6.2. MONONUCLEOSIS DIAGNOSTIC - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MONONUCLEOSIS DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2027 - TEST TYPE
7.1. OVERVIEW
7.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
7.3. EPSTEIN BARR VIRUS (EBV) ANTIBODY TEST
7.3.1. Overview
7.3.2. Epstein Barr Virus (EBV) Antibody Test Market Forecast and Analysis
7.4. COMPLETE BLOOD COUNT TEST
7.4.1. Overview
7.4.2. Complete Blood Count Test Market Forecast and Analysis
7.5. MONOSPOT TEST
7.5.1. Overview
7.5.2. Monospot Test Market Forecast and Analysis
8. MONONUCLEOSIS DIAGNOSTIC MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. LABORATORIES
8.4.1. Overview
8.4.2. Laboratories Market Forecast and Analysis
8.5. OTHER END USERS
8.5.1. Overview
8.5.2. Other End Users Market Forecast and Analysis
9. MONONUCLEOSIS DIAGNOSTIC MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Mononucleosis Diagnostic Market Overview
9.1.2 North America Mononucleosis Diagnostic Market Forecasts and Analysis
9.1.3 North America Mononucleosis Diagnostic Market Forecasts and Analysis - By Test Type
9.1.4 North America Mononucleosis Diagnostic Market Forecasts and Analysis - By End User
9.1.5 North America Mononucleosis Diagnostic Market Forecasts and Analysis - By Countries
9.1.5.1 United States Mononucleosis Diagnostic Market
9.1.5.1.1 United States Mononucleosis Diagnostic Market by Test Type
9.1.5.1.2 United States Mononucleosis Diagnostic Market by End User
9.1.5.2 Canada Mononucleosis Diagnostic Market
9.1.5.2.1 Canada Mononucleosis Diagnostic Market by Test Type
9.1.5.2.2 Canada Mononucleosis Diagnostic Market by End User
9.1.5.3 Mexico Mononucleosis Diagnostic Market
9.1.5.3.1 Mexico Mononucleosis Diagnostic Market by Test Type
9.1.5.3.2 Mexico Mononucleosis Diagnostic Market by End User
9.2. EUROPE
9.2.1 Europe Mononucleosis Diagnostic Market Overview
9.2.2 Europe Mononucleosis Diagnostic Market Forecasts and Analysis
9.2.3 Europe Mononucleosis Diagnostic Market Forecasts and Analysis - By Test Type
9.2.4 Europe Mononucleosis Diagnostic Market Forecasts and Analysis - By End User
9.2.5 Europe Mononucleosis Diagnostic Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Mononucleosis Diagnostic Market
9.2.5.1.1 Germany Mononucleosis Diagnostic Market by Test Type
9.2.5.1.2 Germany Mononucleosis Diagnostic Market by End User
9.2.5.2 France Mononucleosis Diagnostic Market
9.2.5.2.1 France Mononucleosis Diagnostic Market by Test Type
9.2.5.2.2 France Mononucleosis Diagnostic Market by End User
9.2.5.3 Italy Mononucleosis Diagnostic Market
9.2.5.3.1 Italy Mononucleosis Diagnostic Market by Test Type
9.2.5.3.2 Italy Mononucleosis Diagnostic Market by End User
9.2.5.4 Spain Mononucleosis Diagnostic Market
9.2.5.4.1 Spain Mononucleosis Diagnostic Market by Test Type
9.2.5.4.2 Spain Mononucleosis Diagnostic Market by End User
9.2.5.5 United Kingdom Mononucleosis Diagnostic Market
9.2.5.5.1 United Kingdom Mononucleosis Diagnostic Market by Test Type
9.2.5.5.2 United Kingdom Mononucleosis Diagnostic Market by End User
9.2.5.6 Rest of Europe Mononucleosis Diagnostic Market
9.2.5.6.1 Rest of Europe Mononucleosis Diagnostic Market by Test Type
9.2.5.6.2 Rest of Europe Mononucleosis Diagnostic Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Mononucleosis Diagnostic Market Overview
9.3.2 Asia-Pacific Mononucleosis Diagnostic Market Forecasts and Analysis
9.3.3 Asia-Pacific Mononucleosis Diagnostic Market Forecasts and Analysis - By Test Type
9.3.4 Asia-Pacific Mononucleosis Diagnostic Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Mononucleosis Diagnostic Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Mononucleosis Diagnostic Market
9.3.5.1.1 Australia Mononucleosis Diagnostic Market by Test Type
9.3.5.1.2 Australia Mononucleosis Diagnostic Market by End User
9.3.5.2 China Mononucleosis Diagnostic Market
9.3.5.2.1 China Mononucleosis Diagnostic Market by Test Type
9.3.5.2.2 China Mononucleosis Diagnostic Market by End User
9.3.5.3 India Mononucleosis Diagnostic Market
9.3.5.3.1 India Mononucleosis Diagnostic Market by Test Type
9.3.5.3.2 India Mononucleosis Diagnostic Market by End User
9.3.5.4 Japan Mononucleosis Diagnostic Market
9.3.5.4.1 Japan Mononucleosis Diagnostic Market by Test Type
9.3.5.4.2 Japan Mononucleosis Diagnostic Market by End User
9.3.5.5 South Korea Mononucleosis Diagnostic Market
9.3.5.5.1 South Korea Mononucleosis Diagnostic Market by Test Type
9.3.5.5.2 South Korea Mononucleosis Diagnostic Market by End User
9.3.5.6 Rest of Asia-Pacific Mononucleosis Diagnostic Market
9.3.5.6.1 Rest of Asia-Pacific Mononucleosis Diagnostic Market by Test Type
9.3.5.6.2 Rest of Asia-Pacific Mononucleosis Diagnostic Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Mononucleosis Diagnostic Market Overview
9.4.2 Middle East and Africa Mononucleosis Diagnostic Market Forecasts and Analysis
9.4.3 Middle East and Africa Mononucleosis Diagnostic Market Forecasts and Analysis - By Test Type
9.4.4 Middle East and Africa Mononucleosis Diagnostic Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Mononucleosis Diagnostic Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Mononucleosis Diagnostic Market
9.4.5.1.1 South Africa Mononucleosis Diagnostic Market by Test Type
9.4.5.1.2 South Africa Mononucleosis Diagnostic Market by End User
9.4.5.2 Saudi Arabia Mononucleosis Diagnostic Market
9.4.5.2.1 Saudi Arabia Mononucleosis Diagnostic Market by Test Type
9.4.5.2.2 Saudi Arabia Mononucleosis Diagnostic Market by End User
9.4.5.3 U.A.E Mononucleosis Diagnostic Market
9.4.5.3.1 U.A.E Mononucleosis Diagnostic Market by Test Type
9.4.5.3.2 U.A.E Mononucleosis Diagnostic Market by End User
9.4.5.4 Rest of Middle East and Africa Mononucleosis Diagnostic Market
9.4.5.4.1 Rest of Middle East and Africa Mononucleosis Diagnostic Market by Test Type
9.4.5.4.2 Rest of Middle East and Africa Mononucleosis Diagnostic Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Mononucleosis Diagnostic Market Overview
9.5.2 South and Central America Mononucleosis Diagnostic Market Forecasts and Analysis
9.5.3 South and Central America Mononucleosis Diagnostic Market Forecasts and Analysis - By Test Type
9.5.4 South and Central America Mononucleosis Diagnostic Market Forecasts and Analysis - By End User
9.5.5 South and Central America Mononucleosis Diagnostic Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Mononucleosis Diagnostic Market
9.5.5.1.1 Brazil Mononucleosis Diagnostic Market by Test Type
9.5.5.1.2 Brazil Mononucleosis Diagnostic Market by End User
9.5.5.2 Argentina Mononucleosis Diagnostic Market
9.5.5.2.1 Argentina Mononucleosis Diagnostic Market by Test Type
9.5.5.2.2 Argentina Mononucleosis Diagnostic Market by End User
9.5.5.3 Rest of South and Central America Mononucleosis Diagnostic Market
9.5.5.3.1 Rest of South and Central America Mononucleosis Diagnostic Market by Test Type
9.5.5.3.2 Rest of South and Central America Mononucleosis Diagnostic Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MONONUCLEOSIS DIAGNOSTIC MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MONONUCLEOSIS DIAGNOSTIC MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIO-RAD LABORATORIES, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. THERMO FISHER SCIENTIFIC INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. DANAHER CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CARDINAL HEALTH, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. IMMUNOSTICS INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. QUIDEL CORPORATION
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SEKISUI DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MERIDIAN BIOSCIENCE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. Bio-Rad Laboratories, Inc.
3. Thermo Fisher Scientific Inc.
4. Danaher Corporation
5. Cardinal Health, Inc.
6. F. Hoffmann-La Roche Ltd
7. Immunostics Inc.
8. Quidel Corporation
9. Sekisui Diagnostics
10. Meridian Bioscience
TIPRE00019689
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking